In vitro evaluation of the hepatic lipid accumulation of bisphenol analogs: A high-content screening assay

Qian Liu,Wentao Shao,Zhenkun Weng,Xin Zhang,Guipeng Ding,Cheng Xu,Jin Xu,Zhaoyan Jiang,Aihua Gu
DOI: https://doi.org/10.1016/j.tiv.2020.104959
IF: 3.685
2020-10-01
Toxicology in Vitro
Abstract:<p>Bisphenol A (BPA) has a variety of adverse effects on human health; therefore, BPA analogs are increasingly being used as replacements. Notably, recent studies have revealed that BPA exposure induced hepatic lipid accumulation, but few studies are available regarding the similar effects of other bisphenol analogues (BPs). Thus, in the present study, a high-content screening (HCS) assay was performed to simultaneously evaluate the hepatic lipid accumulation of 13 BPs <em>in vitro</em>. The BPs induced lipid deposition in HepG2 cells in the following order: 4,4′-thiodiphenol (TDP) &lt; bisphenol S (BPS) &lt; 4,4′-dihydroxybenzophenone (DHBP) &lt; tetrabromobisphenol A (TBBPA) &lt; tetrachlorobisphenol A (TCBPA) &lt; bisphenol E (BPE) &lt; bisphenol F (BPF) &lt; bisphenol B (BPB) &lt; bisphenol AF (BPAF) &lt; bisphenol A (BPA) &lt; bisphenol C (BPC) &lt; tetramethylbisphenol A (TMBPA) &lt; bisphenol AP (BPAP). Meanwhile, Oil Red O staining and triacylglycerol detection further validated the lipid accumulation elicited by the last 8 BPs, which exhibited a more significant effect on increasing lipid deposition. Mechanistically, significantly increased expression of genes involved in fatty acid synthesis and nuclear receptors and decreased levels of genes associated with fatty acid β-oxidation were observed under BPs treatment. Therefore, the present work is the first to systematically provide direct evidence for BPs-induced hepatic lipid accumulation <em>in vitro via</em> HCS, which can be helpful for safety assessments of BPs.</p>
toxicology
What problem does this paper attempt to address?